新造血原生细胞采集目标对阿菲雷西斯和细胞治疗实验室服务的影响
Aaron J Wyble1, V Rakesh Sethapati1, Steven R Post1
1Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Journal of clinical apheresis
|August 6, 2025
概括
自主造血原生细胞 (HPC) 采集的新目标显著降低了程序和成本. 这一变化简化了表和细胞治疗实验室服务,使患者和医疗保健效率受益.
科学领域:
- 血液学 血液学 血液学
- 细胞疗法细胞疗法
- 在瘤学瘤学.
背景情况:
- 造血干细胞移植依赖于有效的祖细胞采集.
- 随着治疗环境的不断变化,需要对血液形成性恶性瘤的收集目标进行调整.
- 之前对自主HPC的收集目标较高,可能会增加资源利用率.
研究的目的:
- 评估修订自主HPC收集目标对表和细胞治疗实验室 (CTL) 服务的影响.
- 评估程序量,冷保存产品号码以及相关人员和成本的变化.
- 将实施后期的数据与历史控制数据进行比较.
主要方法:
- 追溯分析将2023年4月至12月的数据与2021年4月至12月和2022年4月至12月的数据进行比较.
- 检查患者数量,大容量白血病 (LVL) 程序,冷保存袋,以及员工工作时间/费用.
- 使用单向ANOVA与Tukey多重比较的统计分析.
主要成果:
- 在2023年,与两次控制期相比,LVL手术,冷袋,工作人员工作时间和成本的患者平均值显著下降.
- 每月的分析显示了2023年和2021年之间的显著差异,但2023年和2022年之间没有显著差异.
- 在两个控制期 (2021年与2022年) 之间没有观察到任何显著差异.
结论:
- 修订后的自主HPC采集目标有效地减少了每个患者所需的LVL手术和冷保存袋的数量.
- 这些变化导致了显著的成本削减,并减少了阿菲雷斯和CTL服务的工作量.
- 更新的收集目标使患者的需求与细胞治疗中的高效资源管理保持一致.
相关概念视频
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Bone Marrow Sampling and Transplants
500
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
500
Hematopoiesis
5.7K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.7K
Lineage Commitment
3.1K
Commitment is the process whereby stem cells:
3.1K
Overview of Hematopoiesis
4.7K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
4.7K
Stem Cell Therapy for Tissue Regeneration
4.2K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K


